Hazem Ghebeh

13PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 28, 2026
Tumor-Intrinsic PD-L1 Promotes Breast Cancer Proliferation Through Livin and Galectin-1-Mediated Regulation of SKP2 Expression.

Marwa Elfoly, Ayodele Alaiya, Amal A Al-Hazzani

|Dec 30, 2025
Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Infusional Gemcitabine: Immune Cell Infiltration Analysis and Updated Survival.

Shouki Bazarbashi, Hadeel AlManea, Ali Aljubran

|Dec 10, 2025
Fascin Drives Breast Cancer Cell Proliferation Partly by Modulating the Cell Cycle Checkpoint Regulators of the G1-S Phase.

Hazem Ghebeh, Huda K Al-Nasrallah, Marwa Elfoly

|Sep 13, 2025
Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44hi/CD24lo-ALDH1hi as an Independent Prognostic Factor After Neoadjuvant Chemotherapy.

Hazem Ghebeh, Jumanah Y Mirza, Taher Al-Tweigeri

|Jul 12, 2025
High Tumoral CD24 Expression and Low CD3+ Tumor-Infiltrating Lymphocytes as a Biomarker for High-Risk Locally Advanced Nasopharyngeal Carcinoma.

Hazem Ghebeh, Jumanah Y Mirza, Shamayel F Mohammed

|Jul 27, 2024
Comparative Analysis of Breast Cancer Metabolomes Highlights Fascin's Central Role in Regulating Key Pathways Related to Disease Progression.

Reem H AlMalki, Huda K Al-Nasrallah, Alanoud Aldossry

Pageof 3

Frequent Collaborators

5 joint publications

Monther Al-Alwan

2 joint publications

Taher Al-Tweigeri

1 joint publications

Dilek Colak

1 joint publications

Amal Qattan